Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Juan An

Showing results (101-110 of 136) with videos related to

Pageof 14
Sort By:
Cancer Letters|April 15, 2008
Better survival with EGFR exon 19 than exon 21 mutations in gefitinib-treated non-small cell lung cancer patients is due to differential inhibition of downstream signalsJian-quan Zhu, Wen-zhao Zhong, Guo-chun Zhang, et al.
Cancer Biomarkers : Section a of Disease Markers|June 6, 2013
High expression of truncated GLI3 is associated with poor overall survival in patients with non-small cell lung cancerXiao-Yan Bai, Jia-Ying Lin, Xu-Chao Zhang, et al.
DNA and Cell Biology|October 20, 2022
SPAG5 Activates PI3K/AKT Pathway and Promotes the Tumor Progression and Chemo-Resistance in Gastric CancerJuan An, Lang Yang, Yuanming Pan, et al.
European Journal of Cancer (Oxford, England : 1990)|May 28, 2011
CYP1A1*2A polymorphism as a predictor of clinical outcome in advanced lung cancer patients treated with EGFR-TKI and its combined effects with EGFR intron 1 (CA)n polymorphismQiang Nie, Xue-Ning Yang, She-Juan An, et al.
Food & Function|April 10, 2026
Therapeutic effects of selenium-enriched rapeseed against triple-negative breast cancer: involvement of Resolvin D5 activation and IL-17 signaling inhibitionYuxin Lin, Tangyi Wang, Zhijing Wu, et al.
Chinese Journal of Cancer|May 15, 2014
Detecting the spectrum of multigene mutations in non-small cell lung cancer by Snapshot assayJian Su, Xu-Chao Zhang, She-Juan An, et al.
Cell Regeneration (London, England)|March 18, 2026
HUMSCs repair CCl₄-induced chronic liver injury in rats via metabolic regulationChangpeng Xie, Yiming Dong, Xinxin Yin, et al.
Experimental and Therapeutic Medicine|November 10, 2012
Combinations of laminin 5 with PTEN, p-EGFR and p-Akt define a group of distinct molecular subsets indicative of poor prognosis in patients with non-small cell lung cancerShe-Juan An, Qiu-Xiong Lin, Zhi-Hong Chen, et al.
Annals of Surgical Oncology|December 5, 2012
KRAS mutation in patients with lung cancer: a predictor for poor prognosis but not for EGFR-TKIs or chemotherapyJi-lin Guan, Wen-zhao Zhong, She-juan An, et al.
Oncotargets and Therapy|September 14, 2020
Dysregulation of MiR-30a-3p/Gastrin Enhances Tumor Growth and Invasion throughSTAT3/MMP11 Pathway in Gastric CancerYan Liu, Meng Gao, Juan An, et al.
Pageof 14

Showing results (101-110 of 136) with videos related to

Sort By:
Pageof 14
Cancer Letters|April 15, 2008
Better survival with EGFR exon 19 than exon 21 mutations in gefitinib-treated non-small cell lung cancer patients is due to differential inhibition of downstream signalsJian-quan Zhu, Wen-zhao Zhong, Guo-chun Zhang, et al.
Cancer Biomarkers : Section a of Disease Markers|June 6, 2013
High expression of truncated GLI3 is associated with poor overall survival in patients with non-small cell lung cancerXiao-Yan Bai, Jia-Ying Lin, Xu-Chao Zhang, et al.
DNA and Cell Biology|October 20, 2022
SPAG5 Activates PI3K/AKT Pathway and Promotes the Tumor Progression and Chemo-Resistance in Gastric CancerJuan An, Lang Yang, Yuanming Pan, et al.
European Journal of Cancer (Oxford, England : 1990)|May 28, 2011
CYP1A1*2A polymorphism as a predictor of clinical outcome in advanced lung cancer patients treated with EGFR-TKI and its combined effects with EGFR intron 1 (CA)n polymorphismQiang Nie, Xue-Ning Yang, She-Juan An, et al.
Food & Function|April 10, 2026
Therapeutic effects of selenium-enriched rapeseed against triple-negative breast cancer: involvement of Resolvin D5 activation and IL-17 signaling inhibitionYuxin Lin, Tangyi Wang, Zhijing Wu, et al.
Chinese Journal of Cancer|May 15, 2014
Detecting the spectrum of multigene mutations in non-small cell lung cancer by Snapshot assayJian Su, Xu-Chao Zhang, She-Juan An, et al.
Cell Regeneration (London, England)|March 18, 2026
HUMSCs repair CCl₄-induced chronic liver injury in rats via metabolic regulationChangpeng Xie, Yiming Dong, Xinxin Yin, et al.
Experimental and Therapeutic Medicine|November 10, 2012
Combinations of laminin 5 with PTEN, p-EGFR and p-Akt define a group of distinct molecular subsets indicative of poor prognosis in patients with non-small cell lung cancerShe-Juan An, Qiu-Xiong Lin, Zhi-Hong Chen, et al.
Annals of Surgical Oncology|December 5, 2012
KRAS mutation in patients with lung cancer: a predictor for poor prognosis but not for EGFR-TKIs or chemotherapyJi-lin Guan, Wen-zhao Zhong, She-juan An, et al.
Oncotargets and Therapy|September 14, 2020
Dysregulation of MiR-30a-3p/Gastrin Enhances Tumor Growth and Invasion throughSTAT3/MMP11 Pathway in Gastric CancerYan Liu, Meng Gao, Juan An, et al.
Pageof 14